Cancer treatment boosted by study to identify risk of brain tumour

Cancer treatment has been boosted by the findings of a recent study, which has discovered that variations present in five genes can raise an individual's risk of developing a brain tumour.

Scientists made the discovery as a result of a joint project between the University of Texas M D Anderson Cancer Center and the UK's Institute of Cancer Research.

Although still at an early stage, the researcher's findings are expected to identify those individuals at a heightened risk of developing brain tumours.

Co-senior author Dr Melissa Bondy, professor in M D Anderson's Department of Epidemiology, commented: "This is a ground-breaking study because it's the first time we've had a large enough sample to understand the genetic risk factors related to glioma, which opens the door to understanding a possible cause of these brain tumours."

A glioma is a type of cancer that originates from the glial cells and forms on the spine or in the brain.

Comment on this page »


Latest news

Spire Harpenden Hospital wins prestigious industry award

New testing technique comes to The Royal Marsden

Bupa announce £2.9 million investment

Cancer treatment boosted by study to identify risk of brain tumour
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information